KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Finished Goods (2016 - 2022)

Bio-Rad Laboratories has reported Finished Goods over the past 14 years, most recently at $309.9 million for Q2 2022.

  • Quarterly Finished Goods fell 6.18% to $309.9 million in Q2 2022 from the year-ago period, while the trailing twelve-month figure was $309.9 million through Jun 2022, down 6.18% year-over-year, with the annual reading at $312.6 million for FY2021, 8.97% down from the prior year.
  • Finished Goods was $309.9 million for Q2 2022 at Bio-Rad Laboratories, up from $306.0 million in the prior quarter.
  • Over five years, Finished Goods peaked at $354.1 million in Q1 2018 and troughed at $298.3 million in Q4 2019.
  • The 5-year median for Finished Goods is $331.6 million (2018), against an average of $327.5 million.
  • Year-over-year, Finished Goods decreased 9.81% in 2019 and then rose 15.12% in 2020.
  • A 5-year view of Finished Goods shows it stood at $330.8 million in 2018, then dropped by 9.81% to $298.3 million in 2019, then grew by 15.12% to $343.4 million in 2020, then dropped by 8.97% to $312.6 million in 2021, then fell by 0.88% to $309.9 million in 2022.
  • Per Business Quant, the three most recent readings for BIO's Finished Goods are $309.9 million (Q2 2022), $306.0 million (Q1 2022), and $312.6 million (Q4 2021).